dsm-firmenich scales torula yeast protein to industrial fermentation runs

What Happened

dsm-firmenich is taking its Protopia single-cell protein — made from an optimized torula yeast strain — to a 120,000-liter fermentation run in 2026, with a new Eastern European facility targeting 2,000-10,000 tons a year by 2027. The strain runs on almost any feedstock (ethanol, methanol, acetate, sugar or molasses), yields around 70% protein content, and hits a PDCAAS digestibility score of 0.94-0.96, comparable to animal protein.

Why It Matters

Feedstock-agnostic fermentation solves the single biggest cost variable in single-cell protein — being able to switch between ethanol, molasses or even methanol as input prices shift means the economics aren't hostage to one commodity market, and a 0.94-0.96 PDCAAS score puts it in the same digestibility league as whey or egg.

The strain is the magic, not the facility, not the steel and the concrete.

FET's Takeaway

The line 'the strain is the magic, not the facility' is the real story here for formulators: a licensing model built around a highly optimized microbial strain rather than owning fermentation capacity means this protein could show up cheaply in a lot of regional supply chains at once, not just wherever dsm-firmenich happens to build a plant.